Is Tilray a Textbook Example of a Value Trap?

04:44am, Saturday, 25'th Apr 2026
Tilray exhibits several traits common to stocks that are value traps. However, the company's market leadership and improving balance sheet don't fit the value trap stereotype.
Top insights from the latest market news from Friday, April 24, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Intel results show strong AI demand, cannabis stocks slump after DOJ ruling, and more
Shares of Tilray Brands, Inc. (NASDAQ: TLRY - Get Free Report) dropped 11.8% during trading on Thursday after an insider sold shares in the company. The company traded as low as $6.82 and last traded

The Cannabis Sector's Billion-Dollar Tax Cut

02:40pm, Thursday, 23'rd Apr 2026
On the heels of the executive order to fast-track research into psychedelic drugs, a second major federal policy shift on April 23, 2026, is sending waves through the cannabis sector. However, the rea
Marijuana-related investments were flying high this morning. Then they reversed course, and quickly.
Markets don't usually wait for permission — they anticipate it.

S&P 500, Nasdaq Pare Losses, Nab Record Highs

11:57am, Thursday, 23'rd Apr 2026
Stocks are subdued but up off their sharp open lower as investors wrangle with Iran tensions and earnings reports
Tilray CEO Irwin Simon discusses the expected easing of cannabis restrictions in the US, and why despite not currently selling cannabis in the United States the opportunity to do so would be 'tremendo
Top insights from the latest market news from Thursday, April 23, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday.
The Tilray stock price has risen in the past few days, a trend that accelerated this week. It jumped to a high of $8, up by over 30% from its lowest level this year.
Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients
COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- BrewDog USA by  Tilray Brands, Inc.  (NASDAQ: TLRY; TSX: TLRY), today unveiled its lineup of headliner products and bold innovation bets for spri
Tilray stock shows early reversal signals as U.S. cannabis rescheduling momentum builds, with a breakout and technical strength pointing toward a potential recovery continuation.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE